La artritis reumatoidea es una enfermedad relativamente frecuente y asociada, en muchas oportunidades, con afectación de otros órganos, con el consiguiente aumento de la morbimortalidad. El pulmón es uno de los órganos más comprometidos, por lo que es de crucial importancia tener en consideración esta asociación en pacientes que manifiesten algún trastorno del aparato respiratorio, dado que un diagnóstico precoz y un tratamiento oportuno y adecuado pueden cambiar significativamente la evolución de la enfermedad.

---

Bibliografía del caso clínico
1. Brito Y, Glassberg M, Ascherman D. Rheumatoid arthritis-associated interstitial lung disease. Current concepts. Curr Rheumatol Rep 19(12):79, 2017.
2. Farquhar H, Vassallo R, Edwards A, Matteson E. Pulmonar complications of rheumatoid arthritis. Semin Respir Crit Care Med 40:194-207, 2019.
3. Song X, Lin Q. Genomics, transcriptomics and proteomics to elucidate the pathogenesis of rheumatoid arthritis. Rheumatol Int 37(8):1257-1265, 2017.
4. Klareskog L, Catrina AI, Paget S. Rheumatoid arthritis. Lancet 373(9664):659-672, 2009.
5. Díaz-González F, Hernández-Hernández M. Rheumatoid arthritis Med Clin (Barc) 161(12):533-542, 2023.
6. Marcucci E, Bartoloni E, Alunno A, et al. Extra-articular rheumatoid arthritis. Reumatismo 70(4):212-224, 2018.
7. Alunno A, Gerli R, Giacomelli R, Carubbi F. Clinical, epidemiological, and histopathological features of respiratory involvement in rheumatoid arthritis. Biomed Res Int 7915340, 2017.
8. Figus FA, Piga M, AzzolinI, McConnell R, Iagnocco A. Rheumatoid arthritis H: Extra-articular manifestations and comorbidities. Autoinmun Rev 20(4):102776, 2021.
9. Esposito A, Chu S, Madan R, Doyle T, Dellaripa P. Thoracic manifestations of rheumatoid arthritis. Clin Chest Med 40:545-560, 2019.
10. Koduri G, Norton S, Young A, et al. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology (Oxford) 49(8):1483-1489, 2010.
11. Bongartz T, Nannini C, Medina-Velasquez YF, et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum 62(6):1583-1591, 2010.
12. Kawano-Dourado L, Doyle T, Bonfiglioli K, Sawamura M, Nakagawa R, Arimura F, et al. Baseline characteristics and progression of a spectrum of interstitial lung abnormalities and disease in rheumatoid arthritis. Chest 158(4):1546-1554, 2020.
13. Raimundo K, Solomon JJ, Olson AL, Kong AM, Cole AL, Fischer A, Swigris L. Rheumatoid arthritis - interstitial lung disease in the United States: Prevalence, incidence, and healthcare costs and mortality. J Rheumatol 46(4):360-369, 2019.
14. Sparks JA, Karlson EW. The roles of cigarette smoking and the lung in the transitions between phases of preclinical rheumatoid arthritis. Curr Rheumatol Rep 18(3):15, 2016.
15. Duarte AC, Porter JC, Leandro MJ. The lung in a cohort of rheumatoid arthritis patiente-an overview of different types of involvement and treatment. Rheumatology 58:2031-2038, 2019.
16. Shaw M, Collins BF, Ho LA, Raghu G. Rheumatoid arthritis associated lung disease. Eur Respir Rev 24:1-16, 2015.
17. Iqbal K, Kelly C. Treatment of rheumatoid arthritis associated intersticial lung disease: A perspective review. Ther Ady Musculoskelet Dis 7:247-267, 2015.
18. Dai Y, Wang W, Yu Y, Hu S. Rheumatoid arthritis associated intersticial lung disease: An overview of epidemiology, pathogenesis and management. Clin Rheumatol 40(4):1211-1220, 2021.
19. Castellanos-Moreira R, Rodríguez-García SC, Gomara MJ, Ruiz-Esquide V, Cuervo A, Casafont-Solé I, et al. Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: Evidence of a nnew autoantibody linked to intersticial lung disease. Ann Rheum Dis 79(5):587-594, 2020.
20. Luppi F, Sebastiani M, Salvarini, C, Bendstrup E, Manfredi A. Acute exacerbation of interstitial lung disease associated with rheumatic disease. Nat Rev Rheumatol 18(2):85-96, 2022.
21. Saldarriaga-Rivera LM, López-Villegas VJ. Inhibidor de Janus quinasas como opción terapéutica en artritis reumatoide y enfermedad pulmonar intersticial asociada: reporte de 4 casos. Rev Colomb Reumato 26(2):137-139, 2019.
22. Cassone G, Manfredi A, Vacchi C, Luppi F, Coppi F, Salvarani C, Sebastiani M. Treatment of rheumatoid arthritis-associated interstitial lung disease: lights and shadows. J Clin Med 9(4):1082, 2020.
23. Jolles H, Moseley PL, Peterson MW. Nodular pulmonary opacities in patients with rheumatoid arthritis. A diagnostic dilemma. Chest 96(5):1022-1025, 1989.
24. Montani D, Henry J, O'Connell C, Jaïs X, Cottin V, Launay D, et al. Association between rheumatoid arthritis and pulmonary hypertension: data from the French pulmonary hypertension registry. Respiration 95(4):244-250, 2018.
25. Simon TA, Thompson A, Hochberg KK, Suissa S. Incidence of malignancy in adult patients with rheumatoid arthritis: A meta-analysis. Arthritis Res Ther 17(1):212, 2015.

Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.